• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Advisorshares Pure US Cannabis ETF (NY: MSOS )

    6.050 -0.050 (-0.82%)
    Official Closing Price Updated: 6:30 PM EDT, Aug 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 7,497,671
    Open 6.270
    Bid (Size) 6.020 (1)
    Ask (Size) 6.050 (18)
    Prev. Close 6.100
    Today's Range 6.040 - 6.350
    52wk Range 4.790 - 11.37
    Shares Outstanding 1,244,950
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris
    Congressman Earl Blumenauer, a Democrat from Oregon and co-chair of the Congressional Cannabis Caucus is disappointed the U.S. Drug Enforcement Administration (DEA) opted to delay rescheduling of... 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannabis Stocks Plummet By Up To 16% On DEA Rescheduling Delay: Could This Be The Buying Opportunity Of 2024?
    The market's response was immediate and pronounced. Cannabis stocks plummeted, with MOSOS ETF dropping over 10% in early trading. 
    Via Benzinga
    Topics Cannabis ETFs
    Exposures Cannabis

    Performance

    YTD
    -10.50%
    -10.50%
    1 Month
    -19.55%
    -19.55%
    3 Month
    -24.38%
    -24.38%
    6 Month
    -31.25%
    -31.25%
    1 Year
    +25.52%
    +25.52%

    More News

    Read More
    Key Cannabis Leaders Gather For Networking At Benzinga's Fall 2024 Conference: The Last Big Event Before The Election
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    New SEC Filings Reveal Major Risks In Cannabis ETFs Following Recent Volatility — But There's Still Room for Optimism
    Via Benzinga
    Topics Cannabis ETFs Regulatory Compliance
    Exposures Cannabis Legal Regulatory
    The Trump Card: How Would His Second Term Treat Cannabis?
    Via Benzinga
    Topics Government
    Exposures Political
    The Florida Keys: Cannabis Legalization Brings The Sunshine State Into Focus
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    The Bay Street Butcher: A Cannabis ETF Rebalancing Triggers Volatility
    Via Benzinga
    Topics Cannabis ETFs
    Exposures Cannabis
    The Super Bowl: Cannabis Emerges As A Political Football
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    DEA's Call For Public Input On Cannabis Garnered 42,000 Comments: Majority Want Total Legalization Or Rescheduling
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Atlas Shrugged… And the Market Rallied
    Via Talk Markets
    'Opaque Political Processes,' DEA Rescheduling Deadline, And Now A New Presidential Candidate, It's No Wonder Cannabis Stocks Are Over The Place
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannabis Stocks React To Biden Announcement: Monday's Closing Market Moves
    Via Benzinga
    Topics Cannabis ETFs
    Exposures Cannabis
    Did Pot Just Pivot? Cannabis Preps For Possible Presidential Run
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannabis Stocks Surge Then Plummet On News That Biden Is Bowing Out Of 2024 Presidential Race
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Joe Biden Drops Out: What Would Happen With Cannabis Legalization Under Kamala Harris Or Donald Trump?
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    This Is What a Top Cannabis Executive Thinks Is Going to Happen in the Industry in the Next 10 to 15 Years
    Via The Motley Fool
    Topics Cannabis
    Exposures Cannabis
    Zero Fees, High Hopes: WEED ETF's Strategy To Capitalize On Impending Cannabis Rescheduling
    Via Benzinga
    Topics Cannabis ETFs
    Exposures Cannabis
    Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
    Via Benzinga
    Topics Cannabis Government
    Exposures Cannabis Political
    U.S. Dollar Soars: How Does This Threaten Your Cannabis Investments? Confidential Insights
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    7 Cannabis Stocks to Buy Now: June 2024
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    What Is The Trump Factor? Justice Dept's Impact On Cannabis Rescheduling, Stocks And Investments
    Via Benzinga
    Topics Cannabis Government
    Exposures Cannabis Political
    Why The Time To Invest In U.S. Cannabis Stocks Is Right Now
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    The 3 Most Undervalued Cannabis Stocks to Buy in June 2024
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    Is Tilray Brands Preparing for a Big U.S.-Based Acquisition?
    Via The Motley Fool
    The 2024 Millionaire’s Club: 7 Cannabis Stocks to Buy Now
    Via InvestorPlace
    Topics Cannabis
    Exposures Cannabis
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.